3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
5
Colorectal Neoplasms
4
Colonic Neoplasms
3
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Liver Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Carcinoma Metastatic
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Lymphoid Interstitial Pneumonia
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Interventions
Lenalidomide
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoid Interstitial Pneumonia
×
Lenalidomide
×
Gastrointestinal
×
Clear all
NCT01254617
2020-03-13
ADCC
National Cancer Institute (NCI)
Phase 1
Completed
24 enrolled